IE
NUTX

Israel Englander’s Nutex Health NUTX Stock Holding History

Israel Englander’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.9M Sell
52,107
-37,464
-42% -$4.75M ﹤0.01% 2403
2026
Q1 		$8.51M Buy
89,571
+15,245
+21% +$1.87M ﹤0.01% 2333
2025
Q4 		$12.2M Sell
74,326
-19,070
-20% -$2.53M 0.01% 2044
2025
Q3 		$9.65M Buy
93,396
+61,308
+191% +$6.01M ﹤0.01% 2422
2025
Q2 		$3.99M Sell
32,088
-28,608
-47% -$3.7M ﹤0.01% 3222
2025
Q1 		$2.85M Buy
60,696
+53,969
+802% +$2.63M ﹤0.01% 3443
2024
Q4 		$213K Buy
+6,727
New +$192K ﹤0.01% 5275
2024
Q2 		– Sell
-636
Closed -$9.14K – 6334
2024
Q1 		$9.14K Buy
636
+551
+648% +$11.1K ﹤0.01% 5939
2023
Q4 		$2.29K Buy
+85
New +$2.65K ﹤0.01% 5899
2023
Q3 		– Sell
-13,898
Closed -$879K – 6416
2023
Q2 		$879K Buy
+13,898
New +$1.19M ﹤0.01% 4143
2023
Q1 		– Sell
-290
Closed -$83K – 6700
2022
Q4 		$83K Sell
290
-3,049
-91% -$586K ﹤0.01% 5641
2022
Q3 		$751K Buy
+3,339
New +$1.42M ﹤0.01% 4582

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Israel Englander's NUTX Position: Q2 2026 in Review

Israel Englander reduced its Nutex Health (NUTX) stake by 42% in Q2 2026, selling an estimated $4.75M and leaving 52,107 shares worth $8.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Israel Englander first reported a position in NUTX in Q3 2022 and has held it in 12 quarters since. The position peaked at $12.2M in Q4 2025. 152 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Israel Englander held 52,107 shares of Nutex Health worth $8.9M as of Q2 2026.
  • Israel Englander sold 37,464 Nutex Health shares in Q2 2026, an estimated $4.75M.
  • Nutex Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2403 holding.
  • Israel Englander first reported a position in Nutex Health in Q3 2022 and has held it in 12 quarters since.
  • Israel Englander's Nutex Health position peaked at $12.2M in Q4 2025.
  • 152 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.